Progressive fibrosing interstitial lung disease in rheumatoid arthritis: A retrospective study.

ABSTRACT:

Background and objective

Rheumatoid arthritis associated-interstitial lung disease (RA-ILD) is the most common pulmonary manifestation of rheumatoid arthritis (RA) and an important cause of mortality. In patients suffering from interstitial lung diseases (ILD) from different etiologies (including RA-ILD), a significant proportion is exhibiting a fibrotic progression despite immunosuppressive therapies, defined as progressive fibrosing interstitial lung disease (PF-ILD). Here, we report the frequency of RA-ILD and PF-ILD in all RA patients' cohort at University Hospital of Liège and compare their characteristics and outcomes.

Methods

Patients were retrospectively recruited from 2010 to 2020. PF-ILD was defined based on functional, clinical and/or iconographic progression crit

SUBMITTER: Denis A 

PROVIDER: S-EPMC9748274 | biostudies-literature | 2022

REPOSITORIES: biostudies-literature